Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
No. | 60 |
---|---|
Citation | Circ J 84(6),p975-984(2020) |
Institute | Yokohama City University Medical Center |
1st Author | S Kikuchi |
AR | 〇 |
PL | 〇 |
HD | |
Paper types | Clinical study |
Main purpose | |
Disease | ST-elevation myocardial infarction(STEMI) patients underwent primary percutaneous coronary intervention (PPCI) |
Antiplatelet drug | P2Y12 receptor inhibitors |
Anticoagulant drug | |
Other drug | |
Clinical specimens | |
Animal | |
Keyword | Infarct size; Platelet-derived thrombogenicity; Platelet function test; ST-elevation myocardial infarction |